Psychodynamic approaches that can enable prescribers and clinicians better understand and collaborate in treating these challenging patients.
In the last several decades there has been an increasing emphasis on mental disorders as biologically determined illnesses best treated with medication. Mental health clinicians are educated to identify DSM Axis 1 Disorders and to refer to a prescriber to evaluate the need for medication. Increasingly, mental health clinicians and psychiatrists/prescribers are caring for patients described as “treatment resistant”. These are patients who have failed to recover and who remain impaired despite multiple trials of medication. In this salon, we will review a paper by David Mintz, a psychiatrist from Austin Riggs, who presents the concept of Psychodynamic Psychopharmacology as an approach to treatment resistance. This will be useful to prescribers as well as non-prescribing clinicians who work with these challenging patients.
Objectives
- Become familiar with potential psychodynamic issues underlying pharmacologic treatment resistance.
- Utilize psychodynamic concepts to more effectively treat these patients as a prescriber or therapist.
- For non-prescribing therapists, make use of psychodynamic understanding of pharmacologic treatment resistance to effectively collaborate with prescribers.
Presenter
Alice Silverman MD is a psychiatrist and psychoanalyst who has worked in community mental health and hospital settings and is currently in private practice in Montpelier. She is a past president of the Vermont Psychiatric Association, current president of the Vermont Institute for the Psychotherapies and is an Assistant Clinical Professor in the Dept. of Psychiatry at the University of Vermont Medical School.
Continuing Education
2 CE credits for psychologists, mental health counselors and social workers.
Registration
To register and receive a copy of the paper we will be reviewing contact Alice Silverman alicehersheysilverman@gmail.com

